Advertorial, Bayer. 2017. “Advertorial: EMA REAFFIRMS POSITIVE BENEFIT-RISK BALANCE OF BAYER’S XARELTO® FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION”. SA Heart Journal 13 (1):42-43. https://doi.org/10.24170/13-1-1694.